Skip to content

Now providing Mesenchymal cell-based immunomodulation for Covid19-induced hypercytokinemia. Contact us to learn more

Somata
Genesis Biopharmaceuticals
  • Covid-19
    • Clinical Trials
    • Products
      • Ventilator
  • Treatments
    • Neurodegenerative Diseases
      • Multiple sclerosis
      • Amyotrophic lateral sclerosis
      • Parkinson’s disease
      • Cerebral palsy
      • Autism
    • Diabetes T2
    • Critical limb ischemia
    • Kidney disorder
    • Stroke
  • Biopharmaceuticals
    • Neutrojen
    • Somajen
    • Stem cells
  • Services
    • Bioequivalence
    • Pharmacokinetics
  • Discoveries
    • Multiple Sclerosis
    • COVID-19
  • Contact

Day: April 20, 2018

Big Pharma Suffers Another Major Blow As Study Debunks High Cholesterol Myths, Admitting Statins Are Totally Worthless
Articles

Big Pharma Suffers Another Major Blow As Study Debunks High Cholesterol Myths, Admitting Statins Are Totally Worthless

It’s been a tough few weeks for Big Pharma, as three major studies have now completely disproved the effectiveness of its most profitable drugs. Last week, a huge study published in The Lancet admitted that…

by admin
- Apr. 20, 2018
chat_bubble_outline0
Read morearrow_forward
https://www.facebook.com/somatagenesis
500 E 10th St., Burley, Idaho 83318, USA
USA Tollfree 1 844 518 9699
International +1 646 583 1660
info@somatagenesis.com
  • Neutrojen
  • Somajen
  • Stem cells
  • Bioequivalence
  • Contact
  • COVID-19
  • Multiple Sclerosis Research
Copyright © 2023 Somata Genesis, Inc. | 500 E 10th St., Burley, Idaho 83318, USA
  • Facebook
  • LinkedIn
  • Twitter